JP2020506933A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020506933A5 JP2020506933A5 JP2019542078A JP2019542078A JP2020506933A5 JP 2020506933 A5 JP2020506933 A5 JP 2020506933A5 JP 2019542078 A JP2019542078 A JP 2019542078A JP 2019542078 A JP2019542078 A JP 2019542078A JP 2020506933 A5 JP2020506933 A5 JP 2020506933A5
- Authority
- JP
- Japan
- Prior art keywords
- solid phase
- buffer
- concentration
- protein
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 41
- 108090000623 proteins and genes Proteins 0.000 claims 12
- 102000004169 proteins and genes Human genes 0.000 claims 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 11
- 239000007790 solid phase Substances 0.000 claims 11
- 239000000872 buffer Substances 0.000 claims 9
- 235000002639 sodium chloride Nutrition 0.000 claims 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 8
- 239000007983 Tris buffer Substances 0.000 claims 6
- 238000004587 chromatography analysis Methods 0.000 claims 6
- 239000011780 sodium chloride Substances 0.000 claims 6
- 238000005349 anion exchange Methods 0.000 claims 5
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 5
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims 5
- 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 claims 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 4
- 238000010828 elution Methods 0.000 claims 4
- 230000002209 hydrophobic effect Effects 0.000 claims 4
- 101710137390 P-selectin glycoprotein ligand 1 Proteins 0.000 claims 3
- 230000003993 interaction Effects 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 102100026398 Cyclic AMP-responsive element-binding protein 3 Human genes 0.000 claims 2
- 101000855520 Homo sapiens Cyclic AMP-responsive element-binding protein 3 Proteins 0.000 claims 2
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims 1
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 239000007995 HEPES buffer Substances 0.000 claims 1
- 239000007993 MOPS buffer Substances 0.000 claims 1
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 claims 1
- 108010054395 P-selectin ligand protein Proteins 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- UZMAPBJVXOGOFT-UHFFFAOYSA-N Syringetin Natural products COC1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UZMAPBJVXOGOFT-UHFFFAOYSA-N 0.000 claims 1
- 239000007994 TES buffer Substances 0.000 claims 1
- 239000007997 Tricine buffer Substances 0.000 claims 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims 1
- 239000001166 ammonium sulphate Substances 0.000 claims 1
- 235000011130 ammonium sulphate Nutrition 0.000 claims 1
- 238000000502 dialysis Methods 0.000 claims 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000006471 dimerization reaction Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 239000012160 loading buffer Substances 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 229940085991 phosphate ion Drugs 0.000 claims 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims 1
- 229910052939 potassium sulfate Inorganic materials 0.000 claims 1
- 239000001120 potassium sulphate Substances 0.000 claims 1
- 235000011151 potassium sulphates Nutrition 0.000 claims 1
- 238000002305 strong-anion-exchange chromatography Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17155366 | 2017-02-09 | ||
| EP17155366.2 | 2017-02-09 | ||
| PCT/EP2018/052889 WO2018146067A1 (en) | 2017-02-09 | 2018-02-06 | Process for the purification of soluble psgl-1 protein variants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020506933A JP2020506933A (ja) | 2020-03-05 |
| JP2020506933A5 true JP2020506933A5 (enExample) | 2021-01-28 |
| JP7065105B2 JP7065105B2 (ja) | 2022-05-11 |
Family
ID=58016581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019542078A Active JP7065105B2 (ja) | 2017-02-09 | 2018-02-06 | 可溶性psgl-1タンパク質変異体の精製のための方法 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3580231A1 (enExample) |
| JP (1) | JP7065105B2 (enExample) |
| CN (1) | CN110536896A (enExample) |
| WO (1) | WO2018146067A1 (enExample) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6277975B1 (en) | 1992-10-23 | 2001-08-21 | Genetics Institute, Inc. | Fusions of P-selectin ligand protein and polynucleotides encoding same |
| US5843707A (en) * | 1992-10-23 | 1998-12-01 | Genetics Institute, Inc. | Nucleic acid encoding a novel P-selectin ligand protein |
| DK1681298T3 (da) * | 2000-03-27 | 2010-06-14 | Genetics Inst Llc | Fremgangsmåder til oprensning af særdeles anioniske proteiner |
| EP1736538A1 (en) | 2005-06-21 | 2006-12-27 | Cytos Biotechnology AG | Process for the preparative purification of virus-like-particles (VLPs) |
| BRPI0716139A2 (pt) * | 2006-08-28 | 2013-09-17 | Ares Trading Sa | processo para purificaÇço de proteÍnas de fusço fc |
| US20080274501A1 (en) | 2007-05-02 | 2008-11-06 | Chenming Zhang | Method of purifying acidic proteins expressed in plants |
| EP2350130B1 (en) | 2008-10-31 | 2018-10-03 | Wyeth LLC | Purification of acidic proteins using ceramic hydroxyapatite chromatography |
| EP3395423B1 (en) * | 2013-03-14 | 2023-09-20 | Amgen Inc. | Removal of leaked affinity purification ligand |
| CN108699130A (zh) * | 2016-02-09 | 2018-10-23 | 博莱科瑞士股份有限公司 | 用于选择素靶向的重组嵌合蛋白 |
-
2018
- 2018-02-06 EP EP18703583.7A patent/EP3580231A1/en active Pending
- 2018-02-06 CN CN201880010814.XA patent/CN110536896A/zh active Pending
- 2018-02-06 WO PCT/EP2018/052889 patent/WO2018146067A1/en not_active Ceased
- 2018-02-06 JP JP2019542078A patent/JP7065105B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Greaser et al. | Troponin subunits and their interactions | |
| JP2016504040A5 (enExample) | ||
| JP2013517284A5 (enExample) | ||
| HRP20192080T1 (hr) | Terapeutske fuzije nukleaza-albumine i postupci | |
| JP2011510303A5 (enExample) | ||
| EP2300497A1 (en) | A process of purifying coagulation factor viii | |
| JP2018532725A5 (enExample) | ||
| CA2793136A1 (en) | A process for purifying vitamin k dependent proteins such as coagulation factor ix | |
| FI3811967T3 (fi) | Biologisesti aktiivisten kompleksien valmistus | |
| RU2014107743A (ru) | Очищенные белки | |
| Srinivasan et al. | Functional characterization of solute carrier (SLC) 26/sulfate permease (SulP) proteins in membrane mimetic systems | |
| Islam et al. | Isolation and characterization of vascular smooth muscle inositol 1, 4, 5-trisphosphate receptor | |
| RS50960B (sr) | Postupak za prečišćavanje eritropoetina | |
| US10240136B2 (en) | β-fructofuranosidase | |
| JP2020506933A5 (enExample) | ||
| JP2011527898A (ja) | リンペプチドおよびその使用 | |
| ES2224245T5 (es) | Purificacion del complejo factor viii mediante cromatografia de inmunoafinidad. | |
| CA3014567A1 (en) | Method for producing activated hepatocyte growth factor (hgf) | |
| Hitchings et al. | A tale of tails: deciphering the contribution of terminal tails to the biochemical properties of two Dps proteins from Streptomyces coelicolor | |
| JP2012530123A5 (enExample) | ||
| Allen et al. | The atomic structure of the virally encoded antifungal protein, KP6 | |
| JP2014518508A5 (enExample) | ||
| CN104650218A (zh) | 一种鱼类前胸腺素α及其应用 | |
| Kong et al. | Purification and identification of lactoferrin from bovine milk | |
| CN118742318A (zh) | 包含补体抑制剂的腹膜透析流体组合物 |